RY
Rhythm Pharma
RYTM·NASDAQBoston MAFounded 2008250 employees
Mid CapbiotechPublicRare DiseaseMetabolic
Platform: Setmelanotide Obesity
Market Cap
$2.5B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (RYTM)
Loading RYTM stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RYT-9424 | RYT-9424 | Phase 2/3 | 2 | CGRP | Endometrial CaGBM | ||
| RYT-3886 | RYT-3886 | Phase 2/3 | 1 | Cl18.2 | ADHDRB | ||
| RYT-8232 | RYT-8232 | Phase 2/3 | 1 | MET | Wilms |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)